Држава: Танзанија
Језик: Енглески
Извор: Tanzania Medicinces & Medical Devices Authority
Atenolol
Shelys Pharmaceuticals Limited, TANZANIA
Atenolol
50mg
Tablets
Shelys Pharmaceuticals Limited, TANZANIA
Physical description: White, circular, biconvex, film coated tablets with a break score on one side and engraved with “TENBLOKA 50” on the other side; Local technical representative: Shelys Pharmaceuticals Limited (9387)
Registered/Compliant
2019-08-02
Summary of Product Characteristics 1. Name of the medicinal product TENBLOKA- 50 (Atenolol 50mg Tablets) 2. Qualitative and quantitative composition Each tablet contains Atenolol 50mg. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet White, circular, biconvex, film coated tablets with a break score on one side and engraved with TENBLOKA 50 on the other side. 4. Clinical particulars 4.1 Therapeutic indications 1. The management of hypertension 2. The management of angina pectoris 3. The management of cardiac dysrhythmias 4. Myocardial infarction: Early intervention in the acute phase and long-term prophylaxis after recovery from myocardial infarction. 4.2 Posology and method of administration Posology Adults Hypertension: Most patients respond to 100mg daily given as a single dose. Some patients, however, will respond to 50mg given as a single daily dose. The effect will be fully established after one to two weeks. A further reduction in blood pressure may be achieved by combining Atenolol with other antihypertensive agents. For example, co-administration of Atenolol with a diuretic provides a highly effective and convenient antihypertensive therapy. Angina: Most patients with angina pectoris will respond to 100mg given orally once daily or 50mg given twice daily. It is unlikely that additional benefit will be gained by increasing the dose. Dysrhythmias: Having controlled the dysrhythmias with intravenous Atenolol a suitable maintenance dosage is 50mg - 100mg daily, given as a single dose. Прочитајте комплетан документ